𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Global proteomics and metabolomics in cancer biomarker discovery

✍ Scribed by Haleem J. Issaq; Stephen D. Fox; King C. Chan; Timothy D. Veenstra

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
166 KB
Volume
34
Category
Article
ISSN
1615-9306

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Chromatography and electrophoresis have been used for the last half‐century to separate small and large molecules. Advances in MS instrumentation and techniques for sample introduction into the mass analyzer (i.e. matrix‐assisted laser desorption/ionization and electrospray ionization), chromatography in all its formats and modes and two‐dimensional gel electrophoresis, including two‐dimensional difference gel electrophoresis, enabled the separation of complex biological mixtures, such as the proteome and the metabolome, in a biological sample. These advances have made it possible to identify compounds that can be used to discriminate between two samples taken from healthy and diseased individuals. The objective is to find proteins or metabolites that can be used as a clinical test for the early diagnosis, prognosis and monitoring of the disease and the outcome of therapy. In this manuscript, we present an overview of what has been achieved in the search for biomarkers, with emphasis on cancer, using separation science and MS.

📜 SIMILAR VOLUMES

Proteomics in biomarker discovery and dr
Proteomics in biomarker discovery and drug development
✍ Qing-Yu He; Jen-Fu Chiu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract Proteomics is a research field aiming to characterize molecular and cellular dynamics in protein expression and function on a global level. The introduction of proteomics has been greatly broadening our view and accelerating our path in various medical researches. The most significant a

Biomarker discovery in lung cancer—promi
Biomarker discovery in lung cancer—promises and challenges of clinical proteomics
✍ Ajit Bharti; Patrick C. Ma; Ravi Salgia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

## Abstract Lung cancer is a devastating illness with an overall poor prognosis. To effectively address this disease, early detection and novel therapeutics are required. Early detection of lung cancer is challenging, in part because of the lack of adequate tumor biomarkers. The goal of this review

Prostate carcinoma tissue proteomics for
Prostate carcinoma tissue proteomics for biomarker discovery
✍ Yaxin Zheng; Ye Xu; Bin Ye; Junyi Lei; Michael H. Weinstein; Michael P. O'Leary; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract ## BACKGROUND The advent of the prostate‐specific antigen (PSA) test has had a profound impact on the diagnosis and treatment of prostate carcinoma. However, the use of PSA levels alone for screening for prostate carcinoma was compromised by the variations in the amount of PSA produced

Mass spectrometry-based clinical proteom
Mass spectrometry-based clinical proteomics: Head-and-neck cancer biomarkers and drug-targets discovery
✍ Ajay Matta; Ranju Ralhan; Leroi V. DeSouza; K.W. Michael Siu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

## Abstract Mass spectrometry (MS)‐based proteomics is a rapidly developing technology for both qualitative and quantitative analyses of proteins, and investigations into protein posttranslational modifications, subcellular localization, and interactions. Recent advancements in MS have made tremend